Table 3 Cost of cases and controls
From: Costs associated with adverse events among acute patients
Cases | Controls (weighted) | p-value | |
|---|---|---|---|
Patients | 91 | 91 (1184 non-weighted) | |
A. Cost: Primary admission, mean EUR [95% CI] | 18,826 [12,417–25,235] | 9321 [6867–11,775] | 0.014 |
B. Cost: 6 months from primary admission minus cost of primary admission, mean EUR [95% CI] | 8607 [4977–12,237] | 3639 [2791–4488] | 0.016 |
C. Cost: 7th to 12th month after the beginning of the primary admission, mean EUR [95% CI] | 623 [156–1090] | 1166 [753–1047] | 0.104 |
D. Cost: Total cost from beginning of primary admission and 12 month onwards, mean EUR [95% CI] | 28,056 [20,997–35,115] | 14,126 [11,295–16,957] | 0.001 |